AIM ImmunoTech
AIM
$0.38
Share price
-2.84%
Change (1 day)
-28.32%
Change (1 year)
Categories
P/S ratio for AIM ImmunoTech (AIM)
P/S ratio as of June 2024 (TTM): 123
According to AIM ImmunoTech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 122.634. At the end of 2023 the company had a P/S ratio of 115.
P/S ratio history for AIM ImmunoTech from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 115 | 7.11% |
| 2022 | 107 | -67.39% |
| 2021 | 329 | -26.47% |
| 2020 | 447 | 1007.04% |
| 2019 | 40.4 | 67.92% |
| 2018 | 24.0 | -4.74% |
| 2017 | 25.2 | -86.04% |
| 2016 | 181 | 20.62% |
| 2015 | 150 | -42.12% |
| 2014 | 259 | -13.11% |
| 2013 | 298 | 52% |
| 2012 | 196 | 19.33% |
| 2011 | 164 | -66.16% |
| 2010 | 485 | -27.54% |
| 2009 | 670 | 537.08% |
| 2008 | 105 | 99.03% |
| 2007 | 52.8 | -66.47% |
| 2006 | 158 | 39.75% |
| 2005 | 113 | 45.1% |
| 2004 | 77.7 | -42.18% |
| 2003 | 134 | -32.99% |
| 2002 | 201 | -45.79% |
| 2001 | 370 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.12 | -99.08% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | -24.57% | 🇺🇸 USA |